CLINICAL USE OF BLOOD LEVELS OF CARDIAC DRUGS = UTILISATION CLINIQUE DES TAUX SANGUINS DES MEDICAMENTS A ACTION CARDIAQUEATKINSON AJ JR.1973; MOD. CONCEPTS CARDIOVASCUL. DIS.; U.S.A.; DA. 1973; VOL. 42; NO 1; PP. 1-4; BIBL. 12 REF.Serial Issue

INDIVIDUALIZATION OF ANTICONVULSANT THERAPY = INDIVIDUALISATION DU TRAITEMENT ANTICONVULSIVANTATKINSON AJ JR.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1037-1049; BIBL. 52REF.Article

ANALYSIS OF THE CONTRIBUTIONS OF PERMEABILITY AND FLOW TO INTERCOMPARTMENTAL CLEARANCESTEC GP; ATKINSON AJ JR.1981; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1981; VOL. 9; NO 2; PP. 167-180; BIBL. 29 REF.Article

CLINICAL PHARMACOKINETICSATKINSON AJ JR; KUSHNER W.1979; ANNU. REV. PHARMACOL. TOXICOL.; USA; DA. 1979; NO 19; PP. 105-127; BIBL. 126 REF.Article

SIMULTANEOUS MEASUREMENT OF PLASMA CONCENTRATIONS OF LIDOCAINE AND ITS DESETHYLATED METABOLITE BY MASS FRAGMENTOGRAPHYSTRONG JM; ATKINSON AJ JR.1972; ANAL. CHEM.; U.S.A.; DA. 1972; VOL. 44; NO 14; PP. 2287-2290; BIBL. 15REF.Serial Issue

EFFECT OF CHANGES IN INTERCOMPARTMENT RATE CONSTANTS ON DRUG REMOVAL DURING HEMOPERFUSIONGIBSON TP; ATKINSON AJ JR.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 8; PP. 1178-1179; BIBL. 3 REF.Article

AMPHOTERICIN B PHARMACOKINETICS IN HUMANS.ATKINSON AJ JR; BENNETT JE.1978; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1978; VOL. 13; NO 2; PP. 271-276; BIBL. 17 REF.Article

EFFECT OF ACTIVE DRUG METABOLITES ON PLASMA LEVEL-RESPONSE CORRELATIONS.ATKINSON AJ JR; STRONG JM.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 2; PP. 95-109; BIBL. 1 P. 1/2Article

DIPHENYLHYDANTOIN AS AN ANTIARRHYTHMIC DRUG = LA DIPHENYLHYDANTOINE COMME MEDICATION ANTI-ARYTHMIQUEATKINSON AJ JR; DAVISON R.1974; ANNU. REV. MED.; U.S.A.; DA. 1974; VOL. 25; PP. 99-113; BIBL. 1P.1/2Article

EXCESSIVE SERUM LIDOCAINE LEVELS DURING MAINTENANCE INFUSIONS: MECHANISMS AND PREVENTIONDAVISON R; PARKER M; ATKINSON AJ JR et al.1982; AMERICAN HEART JOURNAL; ISSN 0002-8703; USA; DA. 1982; VOL. 104; NO 2; PART. 1; PP. 203-208; BIBL. 18 REF.Article

RAPID GAS CHROMATOGRAPHIC MEASUREMENT OF PLASMA PROCAINAMIDE CONCENTRATION = MESURE RAPIDE PAR CHROMATOGRAPHIE EN PHASE GAZEUSE DU PROCAINAMIDE PLASMATIQUEATKINSON AJ JR; PARKER M; STRONG J et al.1972; CLIN. CHEM.; U.S.A.; DA. 1972; VOL. 18; NO 7; PP. 643-646; BIBL. 12 REF.Serial Issue

SIMPLE INTERFACE FOR AUTOMATED MASS FRAGMENTOGRAPHY WITH A STANDARD LABORATORY DATA SYSTEMSTRONG JM; ATKINSON AJ JR; FERGUSON RJ et al.1975; ANAL. CHEM.; U.S.A.; DA. 1975; VOL. 47; NO 9; PP. 1720-1721; BIBL. 3 REF.Article

IDENTIFICATION OF GLYCINEXYLIDIDE IN PATIENTS TREATED WITH INTRAVENOUS LIDOCAINESTRONG JM; PARKER M; ATKINSON AJ JR et al.1973; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1973; VOL. 14; NO 1; PP. 67-72; BIBL. 15REF.Serial Issue

PLASMA CONCENTRATIONS OF DESETHYL N-ACETYLPROCAINAMIDE IN PATIENTS TREATED WITH PROCAINAMIDE AND N-ACETYLPROCAINAMIDETSUEN IH RUO; THENOT JP; STEC GP et al.1981; THER. DRUG MONIT.; ISSN 0163-4356; USA; DA. 1981; VOL. 3; NO 3; PP. 231-237; BIBL. 13 REF.Article

HEMODIALYSIS FOR SEVERE PROCAINAMIDE TOXICITY: CLINICAL AND PHARMACOKINETIC OBSERVATIONS.ATKINSON AJ JR; KRUMLOVSKY FA; HUANG CM et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 20; NO 5; PP. 585-592; BIBL. 13 REF.Article

PLASMA LEVELS OF METHSUXIMIDE AND N-DESMETHYLMETHSUXIMIDE DURING METHSUXIMIDE THERAPY = TAUX PLASMATIQUE DE METHSUXIMIDE ET DE N-DESMETHYLMETHSUXIMIDE AU COURS DE LA THERAPEUTIQUE PAR LE METHSUXIMIDESTRONG JM; ABE T; GIBBS EL et al.1974; NEUROLOGY; U.S.A.; DA. 1974; VOL. 24; NO 3; PP. 250-255; BIBL. 14REF.Article

PHARMACOKINETICS OF PENTOBARBITAL IN THE DOGFREDERIKSEN MC; HENTHORN TK; TSUEN IH RUO et al.1983; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1983; VOL. 225; NO 2; PP. 355-360; BIBL. 24 REF.Article

PHARMACOKINETICS IN MAN OF THE N-ACETYLATED METABOLITE OF PROCAINAMIDE.STRONG JM; DUTCHER JS; WOONG KU LEE et al.1975; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1975; VOL. 3; NO 4; PP. 223-235; BIBL. 20 REF.Article

HETEROGENEITY OF INTERSTITIAL FLUID SPACE DEMONSTRATED BY SIMULTANEOUS KINETIC ANALYSIS OF THE DISTRIBUTION AND ELIMINATION OF INULIN AND GALLAMINEHENTHORN TK; AVRAM MJ; FREDERIKSEN MC et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 222; NO 2; PP. 389-394; BIBL. 18 REF.Article

ABSOLUTE BIOAVAILABILITY IN MAN OF N-ACETYLPROCAINAMIDE DETERMINED BY A NOVEL STABLE ISOTOPE METHOD.STRONG JM; DUTCHER JS; WOONG KU LEE et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 613-622; BIBL. 21 REF.Article

ANTIARRHYTHMIC POTENCY OF N-ACETYLPROCAINAMIDEELSON J; STRONG JM; WOONG KU LEE et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 2; PP. 134-140; BIBL. 13REF.Article

EFFICACY AND SAFETY OF N-ACETYLPROCAINAMIDE IN LONG-TERM TREATMENT OF VENTRICULAR ARRHYTHMIASATKINSON AJ JR; LERTORA JJL; KUSHNER W et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 5; PP. 565-576; BIBL. 24 REF.Article

KINETIC OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN RENAL FAILURE.GIBSON TP; ATKINSON AJ JR; MATUSIK E et al.1977; KIDNEY INTERNATION.; GERM.; DA. 1977; VOL. 12; NO 6; PP. 422-429; BIBL. 33 REF.Article

LONG-TERM ANTIARRHYTHMIC THERAPY WITH N-ACETYLPROCAINAMIDELERTORA JJL; ATKINSON AJ JR; KUSHNER W et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 3; PP. 273-282; BIBL. 22 REF.Article

RESIN REMOVAL OF DIGOXIN FROM DOGS.GIBSON T; LUCAS S; NELSON H et al.1977; TRANS., AMER. SOC. ARTIF. INTERN. ORGANS; U.S.A.; DA. 1977; VOL. 23; PP. 606-610; BIBL. 4 REF.Article